Literature DB >> 15961527

Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle.

Christopher M Westerkamp1, Scott E Gordon.   

Abstract

Because optimal overload-induced skeletal muscle hypertrophy requires ANG II, we aimed to determine the effects of blocking ANG II production [via angiotensin-converting enzyme (ACE) inhibition] on potential mediators of hypertrophy in overloaded skeletal muscle, namely, myonuclear addition and fibroblast content. In a 2 x 2 design, adult (200-225 g) female Sprague-Dawley rats were placed into one of four groups (n = 8/group): 7-day skeletal muscle overload, sham operation, 7-day skeletal muscle overload with ACE inhibition, or sham operation with ACE inhibition. Functional overloads of the plantaris and soleus muscles were produced via bilateral surgical ablation of the synergistic gastrocnemius muscle, and ACE inhibition was accomplished by the addition of the ACE inhibitor enalapril maleate to the animals' daily drinking water (0.3 mg/ml). Myonuclear addition and extrasarcolemmal nuclear proliferation, as measured by in vivo 5-bromo-2'-deoxyuridine labeling, were significantly (P < or = 0.05) increased by overload in both the slow-twitch soleus and fast-twitch plantaris muscles. Furthermore, ACE inhibition attenuated these overload-induced increases in the soleus muscle but not in the plantaris muscle. However, the effect of ACE inhibition on soleus extrasarcolemmal nuclei was not likely due to differences in fibroblast content because overload elicited significant increases in vimentin-positive areas in soleus and plantaris muscles, and these areas were unaffected by ACE inhibition in either muscle. There was no effect of ACE inhibition on any measure in sham-operated muscles. Collectively, these data indicate that ANG II may mediate the satellite cell response to overload in slow-twitch soleus but not in fast-twitch plantaris muscles and that this effect may occur independently of changes in fibroblast content.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961527     DOI: 10.1152/ajpregu.00730.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  18 in total

1.  p21(Cip1) expression is increased in ambient oxygen, compared to estimated physiological (5%) levels in rat muscle precursor cell culture.

Authors:  S J Lees; T E Childs; F W Booth
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

2.  Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes.

Authors:  Aldo Matos Costa; António José Silva; Nuno Garrido; Hugo Louro; Daniel Almeida Marinho; Mário Cardoso Marques; Luiza Breitenfeld
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

Review 3.  The renin-angiotensin system and prevention of age-related functional decline: where are we now?

Authors:  Corey B Simon; Brittany Lee-McMullen; Dane Phelan; Janine Gilkes; Christy S Carter; Thomas W Buford
Journal:  Age (Dordr)       Date:  2015-02-09

4.  ACE Inhibitors and Sarcopenia: Covering All the BASEs?

Authors:  Jochen Springer; Stephan von Haehling
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

Review 5.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

6.  Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.

Authors:  Tadashi Yoshida; Sarah Galvez; Sumit Tiwari; Bashir M Rezk; Laura Semprun-Prieto; Yusuke Higashi; Sergiy Sukhanov; Zipora Yablonka-Reuveni; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2013-07-06       Impact factor: 5.157

7.  Effective fiber hypertrophy in satellite cell-depleted skeletal muscle.

Authors:  John J McCarthy; Jyothi Mula; Mitsunori Miyazaki; Rod Erfani; Kelcye Garrison; Amreen B Farooqui; Ratchakrit Srikuea; Benjamin A Lawson; Barry Grimes; Charles Keller; Gary Van Zant; Kenneth S Campbell; Karyn A Esser; Esther E Dupont-Versteegden; Charlotte A Peterson
Journal:  Development       Date:  2011-09       Impact factor: 6.868

8.  Enhanced skeletal muscle regrowth and remodelling in massaged and contralateral non-massaged hindlimb.

Authors:  Benjamin F Miller; Karyn L Hamilton; Zana R Majeed; Sarah M Abshire; Amy L Confides; Amanda M Hayek; Emily R Hunt; Patrick Shipman; Frederick F Peelor; Timothy A Butterfield; Esther E Dupont-Versteegden
Journal:  J Physiol       Date:  2017-12-01       Impact factor: 5.182

Review 9.  Genes for elite power and sprint performance: ACTN3 leads the way.

Authors:  Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

10.  Genetic influence on exercise-induced changes in physical function among mobility-limited older adults.

Authors:  Thomas W Buford; Fang-Chi Hsu; Tina E Brinkley; Christy S Carter; Timothy S Church; John A Dodson; Bret H Goodpaster; Mary M McDermott; Barbara J Nicklas; Veronica Yank; Julie A Johnson; Marco Pahor
Journal:  Physiol Genomics       Date:  2014-01-14       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.